Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
Volume 5 Issue 1
Mar.  2014
Turn off MathJax
Article Contents

PAN Yanpeng, CAO Xianying, WU Zhaoying, CHANG Zhijie, WANG Yinyin, TIAN Bo, HAO Xinbao. The Effect of RNAi Targeting bcr/abl Fusion Gene on the Proliferation Activity of the Chronic Myelogenous Leukemia K562[J]. Journal of Tropical Biology, 2014, 5(1): 25-29. doi: 10.15886/j.cnki.rdswxb.2014.01.016
Citation: PAN Yanpeng, CAO Xianying, WU Zhaoying, CHANG Zhijie, WANG Yinyin, TIAN Bo, HAO Xinbao. The Effect of RNAi Targeting bcr/abl Fusion Gene on the Proliferation Activity of the Chronic Myelogenous Leukemia K562[J]. Journal of Tropical Biology, 2014, 5(1): 25-29. doi: 10.15886/j.cnki.rdswxb.2014.01.016

The Effect of RNAi Targeting bcr/abl Fusion Gene on the Proliferation Activity of the Chronic Myelogenous Leukemia K562

doi: 10.15886/j.cnki.rdswxb.2014.01.016
  • Received Date: 2014-01-17
  • bcr /abl RNAi lentivirus vector was constructed and used to transfect K562 cells( the first human immortalised myelogenous leukemia line to be established),and the stable transfectants were selected. RNAi efficiency was assessed by Real-time PCR and Western blotting. The viability of the K562 cells was detected by CCK-8 assay and clonogenic assay. The results showed that bcr / abl RNAi significantly down regulates the amount of bcr / abl mRNA and P210bcr / abl fusion protein,and inhibits the proliferation of the K562 cells. The method of RNAi targeting bcr / abl fusion gene highlights a new way of chronic myelogenous leukemia treatment.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article views(11) PDF downloads(0) Cited by()

Proportional views
Related

The Effect of RNAi Targeting bcr/abl Fusion Gene on the Proliferation Activity of the Chronic Myelogenous Leukemia K562

doi: 10.15886/j.cnki.rdswxb.2014.01.016

Abstract: bcr /abl RNAi lentivirus vector was constructed and used to transfect K562 cells( the first human immortalised myelogenous leukemia line to be established),and the stable transfectants were selected. RNAi efficiency was assessed by Real-time PCR and Western blotting. The viability of the K562 cells was detected by CCK-8 assay and clonogenic assay. The results showed that bcr / abl RNAi significantly down regulates the amount of bcr / abl mRNA and P210bcr / abl fusion protein,and inhibits the proliferation of the K562 cells. The method of RNAi targeting bcr / abl fusion gene highlights a new way of chronic myelogenous leukemia treatment.

PAN Yanpeng, CAO Xianying, WU Zhaoying, CHANG Zhijie, WANG Yinyin, TIAN Bo, HAO Xinbao. The Effect of RNAi Targeting bcr/abl Fusion Gene on the Proliferation Activity of the Chronic Myelogenous Leukemia K562[J]. Journal of Tropical Biology, 2014, 5(1): 25-29. doi: 10.15886/j.cnki.rdswxb.2014.01.016
Citation: PAN Yanpeng, CAO Xianying, WU Zhaoying, CHANG Zhijie, WANG Yinyin, TIAN Bo, HAO Xinbao. The Effect of RNAi Targeting bcr/abl Fusion Gene on the Proliferation Activity of the Chronic Myelogenous Leukemia K562[J]. Journal of Tropical Biology, 2014, 5(1): 25-29. doi: 10.15886/j.cnki.rdswxb.2014.01.016

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return